celastrol has been researched along with thioacetamide in 2 studies
| Studies (celastrol) | Trials (celastrol) | Recent Studies (post-2010) (celastrol) | Studies (thioacetamide) | Trials (thioacetamide) | Recent Studies (post-2010) (thioacetamide) |
|---|---|---|---|---|---|
| 885 | 1 | 741 | 1,705 | 4 | 655 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anamalai, M; Deshmukh, S; Kaushal, S; Mishra, R; Patel, J; Sharma, S; Simpson, D; Singh, IS; Walker, BL; Zampino, M | 1 |
| Bao, WM; Cheng, Y; Gonzalez, FJ; Hu, DD; Hu, JP; Jiang, T; Li, F; Liu, F; Tang, YM; Xiao, XR; Yang, JH; Zhao, Q | 1 |
2 other study(ies) available for celastrol and thioacetamide
| Article | Year |
|---|---|
Celastrol, an oral heat shock activator, ameliorates multiple animal disease models of cell death.
Topics: Animals; Apoptosis; Cardiomyopathies; Cell Line, Tumor; Cell Survival; Disease Models, Animal; DNA-Binding Proteins; Doxorubicin; GATA4 Transcription Factor; Gene Expression; Heat Shock Transcription Factors; Heat-Shock Proteins; Humans; Interleukin-1beta; Interleukin-6; Liver; Liver Failure; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Pentacyclic Triterpenes; Thioacetamide; Transcription Factors; Triterpenes; Tumor Necrosis Factor-alpha | 2015 |
Celastrol Protects From Cholestatic Liver Injury Through Modulation of SIRT1-FXR Signaling.
Topics: 1-Naphthylisothiocyanate; Adult; Animals; Cholestasis, Intrahepatic; Disease Models, Animal; Female; Gene Expression Profiling; Humans; Male; Metabolomics; Mice; Middle Aged; Pentacyclic Triterpenes; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Sirtuin 1; Thioacetamide; Treatment Outcome; Triterpenes | 2019 |